ISHARES IV PLC NASDAQ US BIOTECH UCITS USD(GBP) ACCISHARES IV PLC NASDAQ US BIOTECH UCITS USD(GBP) ACCISHARES IV PLC NASDAQ US BIOTECH UCITS USD(GBP) ACC

ISHARES IV PLC NASDAQ US BIOTECH UCITS USD(GBP) ACC

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪463.65 M‬USD
Fund flows (1Y)
‪17.75 M‬USD
Dividend yield (indicated)
Discount/Premium to NAV
0.3%

About ISHARES IV PLC NASDAQ US BIOTECH UCITS USD(GBP) ACC


Issuer
Blackrock Finance, Inc.
Brand
iShares
Expense ratio
0.35%
Home page
Inception date
Oct 19, 2017
Index tracked
NASDAQ Biotechnology Index
Management style
Passive
ISIN
IE00BYXG2H39
The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Biotechnology
Strategy
Exchange-specific
Weighting scheme
Market cap
Selection criteria
NASDAQ - listed
What's in the fund
Exposure type
StocksBonds, Cash & Other
Health Technology
Stock breakdown by region
100%
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.